Hearing preservation surgery for neurofibromatosis Type 2-related vestibular schwannoma in pediatric patients

Journal of Neurosurgery

Volumn 106, Issue 4 SUPPL., 2007, Pages 255-260

  Slattery III, William H ^a   Fisher, Laurel M ^a   Hitselberger, William ^a   Friedman, Rick A ^a   Brackmann, Derald E ^a  

^a HOUSE EAR INSTITUTE   (United States)

Author keywords

Hearing preservation; Middle fossa; Neurofibromatosis Type 2; Pediatric neurosurgery; Vestibular schwannoma

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; COHORT ANALYSIS; FACIAL NERVE; FEMALE; HEARING; HUMAN; MALE; MIDDLE CRANIAL FOSSA; NEUROFIBROMATOSIS; NEUROMA; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; CHILD; COHORT STUDIES; CRANIAL FOSSA, MIDDLE; FACIAL NERVE; FEMALE; HEARING; HUMANS; MALE; NEUROFIBROMATOSIS 2; NEUROMA, ACOUSTIC; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34248587042     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/ped.2007.106.4.255     Document Type: Article

References (25)

1. Anonymous: Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma). Otolaryngol Head Neck Surg 113:179-180, 1995
2. Arriaga MA, Luxford WM, Berliner KI: Facial nerve function following middle fossa and translabyrinthine acoustic tumor surgery: a comparison. Am J Otol 15:620-624, 1994 (Pubitemid 24290146)
3. Brackmann DE: Middle cranial fossa approach, in House WF, Luetje CM (eds): Acoustic Tumors. Baltimore: University Park Press, 1979, Vol 2, pp 15-41
4. Brackmann DE, Fayad JN, Slattery WH III, Friedman RA, Day JD, Hitselberger WE, et al: Early proactive management of vestibular schwannomas in neurofibromatosis type 2. Neurosurgery 49:274-283, 2001 (Pubitemid 32721055)
5. Brackmann DE, Kwartler JA: A review of acoustic tumors: 1983-1988. Am J Otol 11:216-232, 1990
6. Brackmann DE, Owens RM, Friedman RA, Hitselberger WE, De la Cruz A, House JW, et al: Prognostic factors for hearing preservation in vestibular schwannoma surgery. Am J Otol 21:417-424, 2000 (Pubitemid 30305042)
7. Briggs RJ, Brackmann DE, Baser ME, Hitselberger WE: Comprehensive management of bilateral acoustic neuromas. Current perspectives. Arch Otolaryngol Head Neck Surg 120:1307-1314, 1994 (Pubitemid 24378570)
8. Coatesworth AP, Lalwani AK: Neurofibromatosis type 2, in Jackler RK, Driscoll, CLW (eds): Tumors of the Ear and Temporal Bone. Philadelphia: Lippincott Williams & Wilkins, 2000, pp 405-416
9. Dashner RA, Chakeres DW, Kangarlu A, Schmalbrock P, Christoforidis GA, DePhilip RM: MR imaging visualization of the cerebral microvasculature: a comparison of live and postmortem studies at 8 T. AJNR Am J Neuroradiol 24:1881-1884, 2003 (Pubitemid 37280541)
10. Evans DG, Huson SM, Donnai D, Neary W, Blair V, Newton V, et al: A clinical study of type 2 neurofibromatosis. Q J Med 84:603-618, 1992 (Pubitemid 23007763)
11. Evans DG, Newton V, Neary W, Baser ME, Wallace A, Macleod R, et al: Use of MRI and audiological tests in presymptomatic diagnosis of type 2 neurofibromatosis (NF2). J Med Genet 37:944-947, 2000 (Pubitemid 32002892)
12. Friedman RA, Kesser B, Brackmann DE, Fisher LM, Slattery WH, Hitselberger WE: Long-term hearing preservation after middle fossa removal of vestibular schwannoma. Otolaryngol Head Neck Surg 129:660-665, 2003 (Pubitemid 37509764)
13. Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, et al: The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278:51-57, 1997 (Pubitemid 27274517)
14. House JW, Brackmann DE: Facial nerve grading system. Otolaryngol Head Neck Surg 93:146-147, 1985 (Pubitemid 15064413)
15. House WF: Surgical exposure of the internal auditory canal and its contents through the middle cranial fossa. Laryngoscope 71:1363-1385, 1961
16. Kanter WR, Eldridge R, Fabricant R, Allen JC, Koerber T: Central neurofibromatosis with bilateral acoustic neuroma: genetic, clinical and biochemical distinctions from peripheral neurofibromatosis. Neurology 30:851-859, 1980 (Pubitemid 10059145)
17. Lim DJ, Rubenstein AE, Evans DG, Jacks T, Seizinger BG, Baser ME, et al: Advances in neurofibromatosis 2 (NF2): a workshop report. J Neurogenet 14:63-106, 2000 (Pubitemid 30429306)
18. Martuza RL, Eldridge R: Neurofibromatosis 2 (bilateral acoustic neurofibromatosis). N Engl J Med 318:684-688, 1988
19. Parry DM, Eldridge R, Kaiser-Kupfer MI, Bouzas EA, Pikus A, Patronas N: Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet 52:450-461, 1994 (Pubitemid 24298996)
20. Shelton C, Brackmann DE, House WF, Hitselberger WE: Middle fossa acoustic tumor surgery: results in 106 cases. Laryngoscope 99:405-408, 1989 (Pubitemid 19103185)
21. Shelton C, Hitselberger WE: The treatment of small acoustic tumors: now or later? Laryngoscope 101:925-928, 1991
22. Shelton C, Hitselberger WE, House WF, Brackmann DE: Hearing preservation after acoustic tumor removal: long-term results. Laryngoscope 100:115-119, 1990 (Pubitemid 20042657)
23. Slattery WH III, Brackmann DE, Hitselberger W: Hearing preservation in neurofibromatosis type 2. Am J Otol 19:638-643, 1998 (Pubitemid 28409420)
24. Slattery WH III, Fisher LM, Iqbal Z, Oppenheimer M, Lev M: Vestibular schwannoma growth rates in NF2 natural history consortium subjects. Otol Neurotol 25:811-817, 2004 (Pubitemid 39223261)
25. Welling DB: Clinical manifestations of mutations in the neurofibromatosis type 2 gene in vestibular schwannomas (acoustic neuromas). Laryngoscope 108:178-189, 1998